IDIX

Idenix Pharmaceuticals, Inc. News Headlines

$24.33
*  
0.01
0.04%
Get IDIX Alerts
*Delayed - data as of Jul. 24, 2014  -  Find a broker to begin trading IDIX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    IDIX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Stocks To Watch: Idenix, Cemex, GoPro...
7/18/2014 7:30:00 AM - Seeking Alpha

Sector Update: Health Care Stocks Ending Mixed; Achillion Pharmaceutical Easing From M&A-Fueled Afternoon Rally
7/11/2014 4:00:00 PM - MT Newswires

Sector Update: Health Care
7/11/2014 3:59:34 PM - MT Newswires

A Pre-Earnings Update On Gilead
7/10/2014 10:59:00 AM - Seeking Alpha

Merck, Gilead Lead Race To Eradicate Hepatitis C
7/3/2014 5:08:00 PM - Investor's Business Daily

Idenix (IDIX) is in Overbought Territory: What's Next? - Tale of the Tape
7/3/2014 9:04:25 AM - Zacks.com

What If Legacy Pharmaceutical And Consumer Business Keeps Falling For Merck?
6/27/2014 6:30:00 PM - Seeking Alpha

Keryx Biopharmaceuticals: Baupost Group's New Position Suggests A Possible Takeout And 100%+ Gains
6/24/2014 8:00:00 AM - Seeking Alpha

Speculators On The Next HCV Acquisition Should Not Overlook Technological Platforms
6/20/2014 10:25:00 AM - Seeking Alpha

Sector Update: Healthcare Shares Flat Pre-Market
6/20/2014 9:07:07 AM - MT Newswires

Merck Begins Tender Offer To Acquire Idenix - Update
6/20/2014 9:03:00 AM - RTT News

Sector Update: Healthcare
6/20/2014 8:59:43 AM - MT Newswires

Merck Begins Tender Offer To Buy Idenix For $24.50/Shr - Quick Facts
6/20/2014 7:36:00 AM - RTT News

Noteworthy ETF Inflows: XBI, IDIX, ACHN, MNKD
6/19/2014 10:49:54 AM - BNK Invest

Why I Love The NASDAQ: The Exchange's Top 10 Performers Year To Date
6/19/2014 10:07:53 AM - Martin Tillier

Hepatitis C May Give A Big Boost To These Drug Stocks - If The FDA Approves
6/17/2014 1:32:00 PM - Seeking Alpha

Maxim's $22 Price Target On Achillion Is Far From Realistic
6/17/2014 3:33:00 AM - Seeking Alpha

If Achillion Was Going To Be Taken Out At A Big Premium, Baupost Would Probably Own It
6/16/2014 5:56:00 PM - Seeking Alpha

AbbVie Gets Priority Review from FDA for HCV Treatment - Analyst Blog
6/16/2014 1:50:00 PM - Zacks.com

Why Big Pharma Has No Interest In Achillion's 'Me Too' Hepatitis C Drug
6/12/2014 8:30:00 AM - Seeking Alpha

Today In SA PRO: Wednesday, June 11
6/12/2014 5:00:00 AM - Seeking Alpha

Biotech ETFs Bounce Back After Three-Month Correction
6/11/2014 6:52:00 PM - Investor's Business Daily

Biotech Stocks Get Turbo Boost From Idenix Deal
6/11/2014 6:45:00 PM - Seeking Alpha

Why Did Merck Pay Such A Huge Premium For Idenix
6/11/2014 6:43:00 PM - Seeking Alpha

Achillion Surges Two Days in a Row, HCV in Focus - Analyst Blog
6/11/2014 5:10:00 PM - Zacks.com